Browse Guides  internal medicine  cardiology

Tachyarrhythmias

Clinical features
Investigations
Therapy
Prevention
Prognosis
Therapy

Wolff-Parkinson-White syndrome

Terminate the rhythm using  diltiazem 0.25 mg/kg a

Why?

  • Diltiazem helps terminate SVT due to re-entrant pathways a

Wolff-Parkinson-White syndrome: diltiazem is more effective than placebo at cardioversion

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
SVT due to re-enterant pathway a diltiazem placebo termination of arrhythmia
at 15 minutes
19% 350%
(100% to 890%)
2
(1 to 2)

Expiry date: July 2004
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   H   Oral
CAT Writers   CM   Ball , N   Shenker , CJ   Wotton